Use of Co-Amoxiclav temporarily suspended amidst reports on fatalities

Date:

Colombo (LNW): The use of Co-Amoxiclav, a class of antibiotics, has been temporarily suspended amidst reports on the death of a patient at the Colombo National Hospital, who was treated with the said antibiotic, announced Health Minister Keheliya Rambukwella.

Early reports claimed that a 50-year old person who had arrived from Warakapola to receive treatment at the Colombo National Hospital for a cut wound died upon being administered the antibiotic.

There were 21,000 vaccines in the relevant drug category, and 18,000 of them have been used so far, but the situation is reported only in relation to one vaccine amongst them, the Minister said.

An investigation is also underway through the expert committee appointed to probe into issues related to medicines, he added.

Share post:

spot_imgspot_img

Popular

More like this
Related

Chamuditha Samarawickrama Tenders Unconditional Apology to Supreme Court and Dr. Wijeyadasa Rajapakshe in Contempt Case

Chamuditha Samarawickrama Tendered Unconditional Apology to the Supreme Court...

Landmark Investment by Synergy Pharmaceuticals to Position Sri Lanka as Regional Pharma Powerhouse

Landmark Investment by Synergy Pharmaceuticals to Position Sri Lanka as Regional Pharma Powerhouse

Hospital Cafeterias Becoming Hubs for Non-Communicable Diseases: Expert Warns of Public Health Risk

Delay in Enforcing Food Regulations Puts Public Health in...

Former MP Athuraliye Rathana Thero Likely to Be Arrested Soon?

Reliable sources report that former Member of Parliament Athuraliye...